Industry News
AgVic's genetic hens join the elites
Agriculture Victoria's 40-year bantamised hen project has entered the commercialisation phase, beginning a joint research deal with an elite international breeder. [ + ]
Australian researchers wasting IP, warns patent expert
Australian researchers were wasting 90 per cent of their intellectual property value because they did not understand how to use it, a patent attorney has warned. [ + ]
Axon releases new drug discovery tool
A screening instrument that enables drug company technicians to run parallel tests has been released by Melbourne-based company Axon Instruments (ASX: AXN). [ + ]
Australian stem cell scientists 'cutting edge'
The world's leading non-profit funder of diabetes research was in Australia this week (February 27) to seek out Australian stem cell scientists. [ + ]
Towards an innovative Victoria
Innovation is the 21st Century driver for economic growth, high quality jobs, wealth and improved living standards, the Minister for Innovation, John Brumby, has said.
[ + ]Shellfish gene helps Brisbane biotech
Brisbane biotech business Xenome Ltd is moving closer to human trials with a pain-killing molecule derived from the venom of a marine shellfish. [ + ]
WA biotech mines double benefit from listing vehicle
Backing hopeful young companies into the listed shells of mining companies is an old habit in Western Australia. [ + ]
Australian biotechs must merge or perish: Ernst and Young
Australia's biotechnology companies will have to merge or perish, according to leading industry analyst Ernst and Young. [ + ]
Xenome chief flags industry insurance fears
There are fears the current insurance industry upheaval will force some biotechs to the wall unless the Gene Technology Act 2000 is overhauled. [ + ]
Sequenom locates Asia HQ in Queensland
US-based genetics company, Sequenom, has chosen Queensland as the location for its Asia-Pacific regional headquarters, Premier Peter Beattie has announced.
[ + ]Mixed signals on stem cells creates concern
Australian stem cell researchers were confused by media reports today that the Federal government had banned human embryonic stem cell research. [ + ]
CSIRO lifting its game: Garrett
CSIRO was well on its way to addressing the raft of serious problems outlined in a confidential internal report, the organisation's chief has claimed. [ + ]
Cone snail proving to be companies' best friend
The cone snail, a marine snail from the Great Barrier Reef, is proving to be a vaulable ally in pain management drug research. [ + ]
MicroMedical's human heart trials imminent
Australia's first artificial hearts are to be implanted in human patients within weeks, according to the developer. [ + ]
Consolidation contributes to Agenix half-year profit
Agenix Limited (ASX: AGH) has announced a 435 per cent increase in after-tax profit to $1.7 million for the six months to December 31, 2001. [ + ]